Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. ampyra.com › is-ampyra-right-for-youIs AMPYRA® (dalfampridine) Right For You?

   ampyra.com › is-ampyra-right-for-you

   • Αποθηκευμένο αντίγραφο

   AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. Do not take AMPYRA if you: are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

2. ampyra.com › what-is-ampyraWhat is AMPYRA® (dalfampridine)?

   ampyra.com › what-is-ampyra

   • Αποθηκευμένο αντίγραφο

   AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

3. www.webmd.com › multiple-sclerosis › ampyria-for-multiple-sclerosis-treatmentAmpyra for MS Treatment: Uses, How It Works, Side-Effects - WebMD

   www.webmd.com › multiple-sclerosis › ampyria-for-multiple-sclerosis-treatment

   • Αποθηκευμένο αντίγραφο

   Ampyra is a drug used to improve the walking ability of people with multiple sclerosis (MS). WebMD explains how Ampyra works, including its side effects.

4. ampyra-hcp.com › ms-walkingMSWS-12 and Walking Speed - ampyra-hcp.com

   ampyra-hcp.com › ms-walking

   • Αποθηκευμένο αντίγραφο

   26 Μαρ 2020 · AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand medication indicated to improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

5. my.clevelandclinic.org › departments › neurologicalUse of Dalfampridine (Ampyra) Fact Sheet | Cleveland Clinic

   my.clevelandclinic.org › departments › neurological

   • Αποθηκευμένο αντίγραφο

   A: Dalfampridine (Ampyra) was approved by the FDA on January 22nd, 2010 as an oral medication to improve walking in patients with MS. Dalfampridine is a symptomatic therapy, and can be used in combination with disease modifying agents. It is an extended release form of 4-aminopyridine (4-AP, also known as fampridine).

6. www.urmc.rochester.edu › news › storyDrug Improves Mobility for Some MS Patients | URMC Newsroom

   www.urmc.rochester.edu › news › story

   • Αποθηκευμένο αντίγραφο

   26 Φεβ 2009 · The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis. That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The Lancet.

7. www.nationalmssociety.org › article › medications-walking-gait-difficultiesMedication and Device for Walking Difficulties | National MS...

   www.nationalmssociety.org › article › medications-walking-gait-difficulties

   Medication can play a crucial role in alleviating multiple sclerosis symptoms — including issues with walking or gait. MS can lead to a variety of mobility issues, ranging from mild unsteadiness to more profound difficulties in walking.